{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:03:12Z","timestamp":1793811792183,"version":"4.6.1"},"reference-count":13,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2020,7,1]]},"DOI":"10.1001\/jamacardio.2020.0640","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T15:32:56Z","timestamp":1587569576000},"page":"757","source":"Crossref","is-referenced-by-count":128,"title":["Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial"],"prefix":"10.1001","volume":"5","author":[{"given":"Mona","family":"Fiuzat","sequence":"first","affiliation":[{"name":"University Medical Center and Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Ezekowitz","sequence":"additional","affiliation":[{"name":"Heart Function Clinic, Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada"},{"name":"Canadian VIGOUR Centre, Katz Group Centre for Pharmacy and Health Research, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendimagegn","family":"Alemayehu","sequence":"additional","affiliation":[{"name":"Canadian VIGOUR Centre, Katz Group Centre for Pharmacy and Health Research, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Westerhout","sequence":"additional","affiliation":[{"name":"Canadian VIGOUR Centre, Katz Group Centre for Pharmacy and Health Research, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sbolli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Brescia, Brescia, Italy"},{"name":"Inova Heart and Vascular Institute, Fairfax, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Cani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Brescia, Brescia, Italy"},{"name":"Inova Heart and Vascular Institute, Fairfax, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Whellan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirkwood","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of North Carolina School of Medicine, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana L.","family":"Pi\u00f1a","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Albert Einstein College of Medicine\/Montefiore Medical Center, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan B.","family":"Patel","sequence":"additional","affiliation":[{"name":"University Medical Center and Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[{"name":"University Medical Center and Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawton S.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mark","sequence":"additional","affiliation":[{"name":"University Medical Center and Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Leifer","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Michael","family":"Felker","sequence":"additional","affiliation":[{"name":"University Medical Center and Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[{"name":"Baim Institute for Clinical Research, Cardiology Division, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"University Medical Center and Duke Clinical Research Institute, Duke University, Durham, North Carolina"},{"name":"Inova Heart and Vascular Institute, Fairfax, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"hoi200016r1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry.","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"hoi200016r2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jchf.2019.03.020","article-title":"Association of changes in heart failure treatment with patients\u2019 health status: real-world evidence from CHAMP-HF.","volume":"7","author":"Thomas","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"18","key":"hoi200016r3","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","article-title":"Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.","volume":"58","author":"Januzzi","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi200016r4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ahj.2009.06.018","article-title":"Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.","volume":"158","author":"Felker","year":"2009","journal-title":"Am Heart J"},{"issue":"1","key":"hoi200016r5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jacc.2009.02.095","article-title":"N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.","volume":"55","author":"Lainchbury","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"hoi200016r6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jchf.2014.05.007","article-title":"Rationale and design of the GUIDE-IT study: Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in heart failure.","volume":"2","author":"Felker","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"8","key":"hoi200016r7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jama.2017.10565","article-title":"Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial.","volume":"318","author":"Felker","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"hoi200016r8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"hoi200016r9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jacc.2019.06.055","article-title":"Natriuretic peptide response and outcomes in chronic heart failure with reduced ejection fraction: insights from the GUIDE-IT trial.","volume":"74","author":"Januzzi","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"hoi200016r10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jchf.2015.11.011","article-title":"Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring.","volume":"4","author":"Costanzo","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"3","key":"hoi200016r11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jacc.2012.03.023","article-title":"Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial.","volume":"60","author":"Fiuzat","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"hoi200016r12","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure.","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"issue":"9704","key":"hoi200016r13","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2764433\/jamacardiology_fiuzat_2020_oi_200016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T15:04:23Z","timestamp":1594825463000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2764433"}},"subtitle":["A Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2020.0640","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,1]]}}}